Abstract
Background:Disparities in the initiation of disease modifying antirheumatic drugs (DMARDs) therapy in ethnic minorities have been described in rheumatoid arthritis (RA)(1). These disparities are of particular concern in view of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
